Transcatheter Aortic Valve Implantation (TAVI)

Dear Colleagues,

Over the last ten years, transcatheter aortic valve implantation (TAVI) has become an important minimally invasive approach that represents an alternative to standard open-heart cardiac surgery for patients at high surgical risk and suffering from severe symptomatic aortic valve stenosis. Based on the results of the most recent clinical trials, this new technology is even additionally recommended for use in patients with an intermediate risk profile and, therefore, the population of patients potentially treatable with a TAVI device is continuing to grow in western countries. Modern cardiac imaging, the computational tools for the 3D imaging analysis of cardiac and vascular structures, and the use of fusion technologies during TAVI procedures have become important key factors for the success of TAVI procedures. Similarly, the evolution of TAVI devices has helped in improving the hemodynamic results, simplifying the procedural steps and lowering the rate of post-TAVI vascular injury, paravalvular leak, and permanent pacemaker implantation. The aim of the present Special Issue is to provide a clear and modern overview on contemporary trends in TAVI and describe, with technical details and clinical data, the latest results and technologies in use during TAVI and valve-in-valve procedures. By reading this Special Issue, modern cardiologists and cardiac surgeons involved in TAVI-dedicated heart teams should easily improve their knowledge by learning about the latest trends in TAVI as presented by experts in the field.

Prof. Dr. Enrico Ferrari
Prof. Dr. Francesco Maisano
Dr. Sergio Berti
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.